ArticleAsian journal of pharmaceutical sciences2025

Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancer.

Guangrui Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.